Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1949 2
1950 1
1953 1
1954 1
1955 2
1956 8
1958 3
1959 5
1960 4
1961 2
1962 1
1963 3
1964 7
1965 5
1966 2
1967 1
1968 5
1969 5
1970 4
1971 1
1972 3
1973 8
1974 6
1975 5
1976 5
1977 16
1978 14
1979 13
1980 25
1981 12
1982 22
1983 26
1984 17
1985 34
1986 19
1987 26
1988 26
1989 38
1990 32
1991 44
1992 33
1993 31
1994 37
1995 21
1996 43
1997 45
1998 42
1999 49
2000 51
2001 59
2002 70
2003 60
2004 60
2005 74
2006 89
2007 99
2008 93
2009 97
2010 98
2011 120
2012 121
2013 150
2014 162
2015 164
2016 198
2017 179
2018 184
2019 170
2020 216
2021 243
2022 205
2023 193
2024 211
2025 179
2026 76

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,925 results

Results by year

Filters applied: . Clear all
Page 1
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study.
Kelly WK, Danila DC, Lin CC, Lee JL, Matsubara N, Ward PJ, Armstrong AJ, Pook D, Kim M, Dorff TB, Fischer S, Lin YC, Horvath LG, Sumey C, Yang Z, Jurida G, Smith KM, Connarn JN, Penny HL, Stieglmaier J, Appleman LJ. Kelly WK, et al. Among authors: fischer s. Cancer Discov. 2024 Jan 12;14(1):76-89. doi: 10.1158/2159-8290.CD-23-0964. Cancer Discov. 2024. PMID: 37861461 Free PMC article.
Compartmentalized ocular lymphatic system mediates eye-brain immunity.
Yin X, Zhang S, Lee JH, Dong H, Mourgkos G, Terwilliger G, Kraus A, Geraldo LH, Poulet M, Fischer S, Zhou T, Mohammed FS, Zhou J, Wang Y, Malloy S, Rohner N, Sharma L, Salinas I, Eichmann A, Thomas JL, Saltzman WM, Huttner A, Zeiss C, Ring A, Iwasaki A, Song E. Yin X, et al. Among authors: fischer s. Nature. 2024 Apr;628(8006):204-211. doi: 10.1038/s41586-024-07130-8. Epub 2024 Feb 28. Nature. 2024. PMID: 38418880 Free PMC article.
Humoral determinants of checkpoint immunotherapy.
Dai Y, Aizenbud L, Qin K, Austin M, Jaycox JR, Cunningham J, Wang EY, Zhang L, Fischer S, Carroll SM, van Aggelen H, Kluger Y, Herold KC, Furchtgott L, Kluger HM, Ring AM. Dai Y, et al. Among authors: fischer s. Nature. 2025 Aug;644(8076):527-536. doi: 10.1038/s41586-025-09188-4. Epub 2025 Jul 23. Nature. 2025. PMID: 40702172
A host-microbiota interactome reveals extensive transkingdom connectivity.
Sonnert ND, Rosen CE, Ghazi AR, Franzosa EA, Duncan-Lowey B, González-Hernández JA, Huck JD, Yang Y, Dai Y, Rice TA, Nguyen MT, Song D, Cao Y, Martin AL, Bielecka AA, Fischer S, Guan C, Oh J, Huttenhower C, Ring AM, Palm NW. Sonnert ND, et al. Among authors: fischer s. Nature. 2024 Apr;628(8006):171-179. doi: 10.1038/s41586-024-07162-0. Epub 2024 Mar 20. Nature. 2024. PMID: 38509360
Identification and validation of extracellular vesicle reference genes for the normalization of RT-qPCR data.
Pinheiro C, Guilbert N, Lippens L, Roux Q, Boiy R, Fischer S, Van Dorpe S, De Craene B, Berx G, Boterberg T, Sys G, Denys H, Miinalainen I, Mestdagh P, Vandesompele J, De Wever O, Hendrix A. Pinheiro C, et al. Among authors: fischer s. J Extracell Vesicles. 2024 Apr;13(4):e12421. doi: 10.1002/jev2.12421. J Extracell Vesicles. 2024. PMID: 38545822 Free PMC article.
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials.
Bar-Or A, Thanei GA, Harp C, Bernasconi C, Bonati U, Cross AH, Fischer S, Gaetano L, Hauser SL, Hendricks R, Kappos L, Kuhle J, Leppert D, Model F, Sauter A, Koendgen H, Jia X, Herman AE. Bar-Or A, et al. Among authors: fischer s. EBioMedicine. 2023 Jul;93:104662. doi: 10.1016/j.ebiom.2023.104662. Epub 2023 Jun 22. EBioMedicine. 2023. PMID: 37354600 Free PMC article. Clinical Trial.
Editorial.
Ghadimi M, Kalff J, Keck T, Fischer S. Ghadimi M, et al. Among authors: fischer s. Zentralbl Chir. 2025 Feb;150(1):26-27. doi: 10.1055/a-2481-5843. Epub 2025 Feb 5. Zentralbl Chir. 2025. PMID: 39909056 German. No abstract available.
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Knox JJ, O'Kane G, King D, Laheru D, Habowski AN, Yu K, Perez K, Aguirre AJ, Coyne Z, Harvey H, McLaughlin RA, Jang RW, Grant RC, Elimova EC, Renouf DJ, Fischer S, Duan K, Ramotar S, Jang GH, Zhang A, Devoe CE, Singh H, Pishvaian MJ, Froeling FEM, Saif MW, O'Reilly EM, Tsang ES, Wolpin BM, Wilson JM, Dodd A, Pugh TJ, Ye XY, Gallinger S, Tuveson DA, Notta F, Jaffee EM. Knox JJ, et al. Among authors: fischer s. J Clin Oncol. 2025 Nov;43(31):3355-3368. doi: 10.1200/JCO-25-00436. Epub 2025 Sep 10. J Clin Oncol. 2025. PMID: 40929627 Clinical Trial.
Lithium in plants.
Garcia-Daga S, Fischer S, Gilliham M. Garcia-Daga S, et al. Among authors: fischer s. New Phytol. 2025 Nov;248(4):1639-1654. doi: 10.1111/nph.70523. Epub 2025 Sep 21. New Phytol. 2025. PMID: 40976974 Free PMC article. Review.
3,925 results